በTexas ለራብዶሚዮሳርኮማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለራብዶሚዮሳርኮማ የሚደረጉ 9 ጥናቶች በTexas ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በTexas ውስጥ ያሉ ከተሞች
Official study text (English)
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- University of Texas - MD Anderson Cancer Center, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 1
24 Months – 18 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06441331Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Children's Medical Center, Dallas
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እስከ እድሜ 30 · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06541262A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
- Dell Children's Medical Center of Central Texas, Austin
- Driscoll Children's Hospital, Corpus Christi
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እስከ እድሜ 50 · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT07466316Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
- Texas Children's Hospital, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ1 እስከ 21 · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT04715191PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
- Texas Children's Hospital, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ1 እስከ 30 · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁላይ 2026 · NCT06721689Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
- Cook Children's Medical Center, Fort Worth
ተሳታዮችን በመፈለግ ላይደረጃ 2
እስከ እድሜ 22 · ሁሉም ጾታዎች · የተሻሻለው በ15 ጁን 2026 · NCT06023641VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
- The University of Texas Southwestern Medical Center, Dallas
- Texas Children's Hospital, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
6 Months – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ2 ጁን 2026 · NCT04796012HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
- Texas Children's Hospital, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ1 እስከ 25 · ሁሉም ጾታዎች · የተሻሻለው በ22 ጃንዩ 2026 · NCT04995003Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
- Houston Methodist Hospital, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 1
እስከ እድሜ 21 · ሁሉም ጾታዎች · የተሻሻለው በ3 ኖቬም 2025 · NCT06198296ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።